McKinsey Opioids – Lieff Cabraser

Plaintiffs’ Counsel Announce that Court Grants Final Approval to McKinsey’s $230M Opioid Settlement with Cities, Counties, and Schools

The law firms of Lieff Cabraser Heimann & Bernstein LLP, Robbins Geller Rudman & Dowd LLP, Simmons Hanly Conroy LLC, Motley Rice LLC, and Browne Pelican PLLC, counsel for plaintiffs in the McKinsey opioids litigation, announce that U.S. District Court Judge Charles Breyer has granted final approval to a $230 million settlement by McKinsey &

LieffCabraser2024-04-25T17:11:27+00:00February 5th, 2024|McKinsey Opioids, Prescription Drug Injuries, Public Good|

McKinsey Consultancy Opioid Epidemic Tribal Settlement Distribution is Underway

On Wednesday, January 17, 2024, a distribution of $32 million was made to federally-recognized Native American Tribes as part of the McKinsey Opioid Epidemic Tribal Settlement. Lieff Cabraser serves as Plaintiffs’ lead counsel in the McKinsey & Co. National Prescription Opiate Litigation, and has been at the forefront of this

LieffCabraser2024-04-25T17:11:09+00:00January 18th, 2024|McKinsey Opioids, Native American Cases, Prescription Drug Injuries|

Title